PLA2G7 and cardiovascular disorder: Because MetS increases the risk of cardiovascular disease and a significant reduction of OxLDL has been observed, our extended study was focused on the assessment of specific biomarkers of oxidative damage to lipids and lipoproteins, including plasma MDA and Lp-PLA2.